Treatment and Outcomes of Crohn&apos;s Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007-23

Inflammatory Bowel Disease

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease

J Gastroenterol Hepatol

Ooi CJ, Ling KL, Limsrivilai J, Wei SC, Mak JWY, Kobayashi T, Dang LM, Leong RW, Lin H, Weng MT, Ong WC, Ahuja V, Aniwan S, Hokari R, Lee WJJ, Leow AH, Leung WK, Lim WC, Makharia G, Matsuoka K, Mustaffa N, Ng SC, Philip M, Pisespongsa P, Ali RAR, Ran ZH, Simadibrata M, Sollano J, Tan M, Viet HD, Wan Ibrahim NR, Wu KC, Ye BD, Hilmi I, Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN‐IBD)

doi: 10.1111/jgh.70379

Inflammatory Bowel Disease

Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study

Clin Gastroenterol Hepatol

Louis E, Sebastian S, Siegmund B, Bossuyt P, Danese S, de Boer N, Loftus EV, Moum B, Peyrin-Biroulet L, Schreiber S, Zhou J, Angellotti E, Adsul S, Jones S, Siegel CA

doi: 10.1016/j.cgh.2025.10.006

Inflammatory Bowel Disease

Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis

Inflamm Bowel Dis

Gan X, Zhang Y, Zhang Y, Ye Z, Yang S, Xiang H, Huang Y, Wu Y, Zhang Y, Qin X

doi: 10.1093/ibd/izaf325

Inflammatory Bowel Disease

Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.

Inflamm Bowel Dis

Rubin DT, Schreiber S, Peyrin-Biroulet L, Danese S, Gianfrancesco MA, Soonasra A, Sidhu S, Vranic I, Shelbaya A, Gruben D, Wei Y, Winthrop KL, Curtis JR, Regueiro MD, Dubinsky MC

doi: 10.1093/ibd/izag142

Inflammatory Bowel Disease

Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis

Adv Ther

Schreiber S, Danese S, Colombel JF, Hisamatsu T, Irving PM, Park H, Kim DH, Lee YN, Hanauer SB

doi: 10.1007/s12325-025-03447-6

Inflammatory Bowel Disease

Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey

J Crohns Colitis

Moreira PL, Dignass A, Estevinho MM, Santiago M, Reinisch W, Sands BE, D'Haens G, Mantzaris GJ, Danese S, Peyrin-Biroulet L, Dotan I, Jairath V, Magro F, International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)

doi: 10.1093/ecco-jcc/jjaf178

Inflammatory Bowel Disease

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

United European Gastroenterol J

Mañosa M, Calafat M, Ricart E, Nos P, Iglesias E, Riestra S, Mesonero F, Calvo M, Guardiola J, Hernández V, Rivero M, Carpio D, Mínguez M, Alba C, Martín-Arranz MD, Vela M, Gomollón F, García-López S, Casbas AG, Calvet X, González-Muñoza C, Barrio J, Gisbert JP, Sicilia B, Pérez-Calle JL, Bujanda L, Esteve M, Ramos L, Varela P, Sierra M, Merino O, Bermejo F, Acosta MB, Perez AR, Márquez-Mosquera L, García-Bosch O, Rodríguez-Lago I, Lorente Poyatos RH, García Sepulcre MF, Maroto N, Vega P, Monfort D, San Martín LZ, Busquets D, Martinez-Montiel P, Riera J, Alcain G, Llaó J, Marin N, Marin-Jimenez I, Sesé E, Van Domselaar M, Huguet JM, Ginard D, Bas-Cutrina F, Ber Y, Roncero O, Lucendo AJ, López-García A, Menacho M, Almela P, Ponferrada Á, Coronel AF, Maestro S, de Jesús Martínez-Pérez T, Vilafranca CM, Argüelles F, Legido J, Gilabert P, Charro M, Trapero AM, Fernández H, Frago S, Villalba LH, Muñoz E, Domènech E, ENEIDA registry of GETECCU

doi: 10.1002/ueg2.70150

Inflammatory Bowel Disease

Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease: a real-world case series

J Crohns Colitis

Farkouh A, Nathoo-Khedri N, Dufresne A, Danaie H, Battat R

doi: 10.1093/ecco-jcc/jjag089

Inflammatory Bowel Disease

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study

J Crohns Colitis

Neri B, Schiavone SC, Mancone R, Fiorillo M, Fonsi A, Calabrese E, Perugini L, Piccione G, Di Matteo FM, Marafini I, Lolli E, Sica GS, Monteleone G, Biancone L

doi: 10.1093/ecco-jcc/jjaf163

Related content

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease

Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study

Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis

Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.

Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis

Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease: a real-world case series

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study